FI20096400A0 - Veriryhmästatuksen käyttö I - Google Patents

Veriryhmästatuksen käyttö I

Info

Publication number
FI20096400A0
FI20096400A0 FI20096400A FI20096400A FI20096400A0 FI 20096400 A0 FI20096400 A0 FI 20096400A0 FI 20096400 A FI20096400 A FI 20096400A FI 20096400 A FI20096400 A FI 20096400A FI 20096400 A0 FI20096400 A0 FI 20096400A0
Authority
FI
Finland
Prior art keywords
blood group
group status
intestine
individual
secretor
Prior art date
Application number
FI20096400A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Pirjo Wacklin
Jaana Maettoe
Harri Maekivuokko
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI20096400A priority Critical patent/FI20096400A0/fi
Publication of FI20096400A0 publication Critical patent/FI20096400A0/fi
Priority to US12/843,404 priority patent/US20110158950A1/en
Priority to CN201080063735.9A priority patent/CN102781466B/zh
Priority to EP10807444A priority patent/EP2519255A2/en
Priority to PCT/FI2010/051093 priority patent/WO2011080395A2/en
Priority to IN6393DEN2012 priority patent/IN2012DN06393A/en
Priority to US13/519,479 priority patent/US20120315250A1/en
Priority to BR112012016926A priority patent/BR112012016926A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI20096400A 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I FI20096400A0 (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I
US12/843,404 US20110158950A1 (en) 2009-12-28 2010-07-26 Use of blood group status i
CN201080063735.9A CN102781466B (zh) 2009-12-28 2010-12-28 与分泌者血型状态相符的益生双歧杆菌组合物
EP10807444A EP2519255A2 (en) 2009-12-28 2010-12-28 Probiotic bifidobacterial composition in accordance with secretor blood group status
PCT/FI2010/051093 WO2011080395A2 (en) 2009-12-28 2010-12-28 Use of blood group status i
IN6393DEN2012 IN2012DN06393A (enExample) 2009-12-28 2010-12-28
US13/519,479 US20120315250A1 (en) 2009-12-28 2010-12-28 Probiotic bifidobacterial composition in accordance with secretor blood group status
BR112012016926A BR112012016926A2 (pt) 2009-12-28 2010-12-28 composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I

Publications (1)

Publication Number Publication Date
FI20096400A0 true FI20096400A0 (fi) 2009-12-28

Family

ID=41462858

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I

Country Status (7)

Country Link
US (1) US20110158950A1 (enExample)
EP (1) EP2519255A2 (enExample)
CN (1) CN102781466B (enExample)
BR (1) BR112012016926A2 (enExample)
FI (1) FI20096400A0 (enExample)
IN (1) IN2012DN06393A (enExample)
WO (1) WO2011080395A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
US20150265661A1 (en) * 2012-04-13 2015-09-24 Trustees Of Boston College Prebiotic effect of sialyllactose
CN105385762A (zh) * 2015-12-10 2016-03-09 扬州市扬大康源乳业有限公司 一种快速鉴定双歧杆菌的方法
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
AU2002329043A1 (en) * 2001-07-30 2003-02-24 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
JP4709838B2 (ja) * 2004-08-05 2011-06-29 アニドラル エス．アール．エル． 葉酸産生ビフィドバクテリウム菌株、製剤およびこれらの用途
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions

Also Published As

Publication number Publication date
CN102781466A (zh) 2012-11-14
WO2011080395A2 (en) 2011-07-07
EP2519255A2 (en) 2012-11-07
US20110158950A1 (en) 2011-06-30
WO2011080395A3 (en) 2011-09-15
CN102781466B (zh) 2015-11-25
IN2012DN06393A (enExample) 2015-10-02
BR112012016926A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
MX367109B (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
AU329027S (en) Diagnostic device
AU342358S (en) Dental bite block
MX382895B (es) Suplemento dietético.
BR112013011259A2 (pt) condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3
PH12015501099A1 (en) Synbiotic composition and use thereof
IN2012DN03404A (enExample)
IN2012DN06392A (enExample)
FI20096400A0 (fi) Veriryhmästatuksen käyttö I
IN2015DN02818A (enExample)
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
AU332374S (en) Lollipops
AU327019S (en) Chair
AU327063S (en) Chair
AU327026S (en) Chair
AU327018S (en) Chair
AU327038S (en) Chair
AU327029S (en) Chair
AU337238S (en) Twin maintenance shaft base
AU335560S (en) Powerpoint
AU335582S (en) Powerpoint

Legal Events

Date Code Title Description
FD Application lapsed